PRINCIPAL: A prospective observational study of real world treatment patterns and treatment outcomes in patients with advanced or metastatic renal cell carcinoma receiving pazopanib (115232)

First published 02/04/2014

Last updated 01/04/2024

EU PAS number:

EUPAS6239

Study

Finalised

Documents

Study protocol

Initial protocol

veg115232-protocol-redacted

English (787.39 KB - PDF) View document

Updated protocol

veg115232-protocol-amend-redact

First published: 22/02/2024

English (1.06 MB - PDF) View document

Study results

PZP034A2401 CSR_Redacted_PDF_A

English (450.76 KB - PDF) View document

Study report

Other information

Secondary tabs